80% of quantum chips fail, QuantaMap is committed to changing that

6 juli 2026

Quantum chips are getting better and better, but no one understands exactly why one chip works and another doesn’t. Johannes Jobst, founder of QuantaMap Imaging, is building the instrument that will finally provide the answer. Based in Leiden, he is working on what he is convinced will become the diagnostic standard for the quantum industry.

The problem that nobody solved

The conventional semiconductor industry has everything under control. It has machines for manufacturing chips as well as diagnostic tools to check that everything is working properly along the way. Without those checks, the chip yield would be around 40 percent instead of the current 80 percent.

For quantum chips, that second part doesn’t exist yet. “You can’t use a standard inspection tool on a quantum chip. You’ll see all sorts of things, but not the defects that actually matter.” Johannes explains.

As a result, the production yield for quantum chips is currently somewhere between 10 and 20 percent. The chips cost millions each, and sometimes a manufacturer sells only one per month.

From university to business

The story of QuantaMap begins across the street from their current office in BioPartner 4, in the laboratories of Leiden University.

There, Johannes and his co-founders, Kaveh Lahabi and Milan Allan, developed a measurement technology that captures unique images of quantum chips at temperatures near absolute zero. At some point, they realized: this isn’t just interesting for science.

“We’re really a classic spin-off. We commercialize technology that was largely developed right here, literally across the street.”

The decision to start a business wasn’t made overnight. For nearly a year, they worked on the business plan in the evenings, mostly as a side project. It wasn’t until the initial funding was secured that Johannes quit his job.

PLNT as a starting point

Before QuantaMap really took off, Kaveh and Milan were looking for guidance. They found it through PLNT’s Venture Academy program.

“As an academic, I knew absolutely nothing about starting a business. It was a crash course in the basics. Now those things seem obvious, but at the time we felt completely lost,” said Kaveh.

At Venture Academy, the team learned about funding options, what investors look for, and how to structure a pitch. But the community surrounding it was just as valuable.

“It was nice to talk to other people going through the same thing. We were able to help each other and figure things out together.”

The network Kaveh built at PLNT later proved to be a real asset. Someone from PLNT put Kaveh in touch with a co-founder of another quantum startup, who then connected him with the right people at QDNL.

“That connection helped us secure our first round of funding and our first loan. Without that introduction, our journey would have looked very different.”

Pitching a hundred times

The biggest challenge in the early stages was figuring out what the company is actually worth to others.

“You need to find the right person within other organizations someone who understands the technology and is in a position of authority to make a purchasing decision.”

The team ended up giving about a hundred pitches before they received any truly useful feedback. Some people were just being polite, and that didn’t help.

“When someone tells you that it’s useless to them, it’s hard to accept at first. But in the end, it helps you a lot more.”

Hardware also comes with its own delays. The lead time for a cryostat, the cooling unit they need, is six months. Spending more money won’t help with that.

Growing in Leiden

QuantaMap got its start in the labs at Leiden University. While essential in the early stages, the space soon became too cramped for a growing company.

The team is now based in a BioPartner 4 building in the heart of the Leiden Bio Science Park, part of the broader ecosystem that also includes PLNT. Leiden is currently working on 8 of the 10 key technologies identified by Europe. Key Region Leiden raises awareness of these key technologies and ensures that stakeholders within the ecosystem can connect with one another. Quantum is one of the key technologies, which QuantaMap works on every day.

Other cities are also easily accessible; for example, QuantaMap actively collaborates with partners such as QuantWare, TNO, and VSSL, almost all of which are based in Delft.

“Delft is just twenty minutes away. It’s really just the same city. In Germany, where I’m from, the next town is often a two-hour drive away,” said Johannes.

That proximity fosters a culture of openness. Companies in the quantum sector know each other, do not view each other as competitors, and actively help one another, even with the less glamorous tasks.

“If I need a lawyer who specializes in intellectual property, I call a few other founders and ask who they recommend. That’s very different from just hearing about a ‘good law firm’ in general.”

What no one had seen before

The images produced by QuantaMap are unique. They are taken at one Kelvin and show how magnetic fields behave and how electric currents meander around defects.

“No one has ever seen this before. We show a customer something, and suddenly they have an explanation for something they’ve been puzzling over for years.”

“They always noticed an unusual signal but never knew why. We made it visible. And they were happy to pay us for that.”

The Dream

In five years, QuantaMap aims to be the go-to choice for quantum chip diagnostics, a position comparable to that of ASML in the traditional chip industry.

The ultimate goal goes beyond market share.

“Ultimately, our instrument needs to be in every quantum chip factory in the world.”

His advice to other researchers with a quantum idea is simple: just get started.

“The Netherlands is a great place to start; there’s capital available. And talk to people who’ve done it before, because almost everyone is willing to share their experiences.”

This interview was written in collaboration with Key Region Leiden.

Share this article

View all latest articles

11 juni 2026
Co-founding the right way with Dr. Jana Nevrlka
On June 11, PLNT welcomed Dr. Jana Nevrlka for a special program day organized b...
28 mei 2026
Akin Solutions is moving to Delft!
After a valuable period within our community, Akin Solutions is taking another s...
21 mei 2026
Gateway Bio wins Audience Award and Rough Diamond Award at the Philips Innovation Awards!
Cool news! Gateway Bio, startup from the unlock_ cohort 2026-2027, won both the ...
12 mei 2026
The new unlock_ cohort has started
As of April, the new unlock_ cohort has begun. Ten Live Sciences & Health st...
16 april 2026
unlock_ cohort 2025-2026 has passed!
Yesterday was the official graduation of the unlock_cohort 2025-2026! The startu...
6 maart 2026
Radigene aims to take cell and gene therapy out of the ‘black box’
Cell and gene therapies offer enormous opportunities for patients with serious d...
2 maart 2026
Gulliver Startup Awards 2026
On Friday, February 27, the festive finals of the Gulliver Startup Awards took p...
18 februari 2026
100th UNIIQ Brick Awarded in Leiden
Pepper Therapeutics, Bactheravax, and Omivera each secured €350,000 in funding f...
22 december 2025
Robert Krams develops personalized treatments for every patient using AI
How do you ensure that every patient, regardless of their illness, receives the ...
15 december 2025
how MyClusters is giving people with cluster headaches more control over their health
How do you help people regain control over their lives when they suffer from one...
15 december 2025
From discovery to impact: How Glyco Diagnostics aims to change the fight against liver fibrosis
Glyco Diagnostics is developing an innovative liver fibrosis test to help diabet...
5 december 2025
VINDI Biosystems detects diseases early using photonics
What if we could treat diseases before a patient even experiences a single sympt...